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970Objective: Coronary artery bypass grafting with multiple internal thoracic artery grafts is currently controver-
sial. This study assessed single institutional outcomes with multiple internal thoracic artery grafting for guidance
with future clinical decisions.
Methods: In 19,482 patients undergoing multivessel coronary artery bypass grafting (1984-2009), baseline
characteristics were recorded in a prospective databank, and follow-up was obtained by questionnaires, phone
contact, or National Death Index. Outcomes examined were subsequent myocardial infarction, percutaneous
coronary intervention, reoperative coronary artery bypass grafting, all-cause death, and a composite of the 4.
Three groups were defined: (1) no internal thoracic artery graft (1874/19,482 or 9%); (2) single internal thoracic
artery grafts and adjunctive venous conduits (single internal thoracic artery; 16,881/19,482 or 87%); and (3)
multiple internal thoracic artery grafts (728/19,482 or 4%). Multivariable Coxmodeling adjusted for differences
in baseline characteristics, and comparisons were performed using area under the curve analysis.
Results: Differences in baseline characteristics for the no internal thoracic artery graft, single internal thoracic
artery, and multiple internal thoracic artery groups were as follows: median age 66, 64, and 59 years, respec-
tively; congestive heart failure 22%, 18%, and 13%, respectively; ejection fraction 0.50, 0.52, and 0.51, respec-
tively; reoperation 10%, 3%, and 7%, respectively; diabetes 27%, 30%, and 15%, respectively; and female
gender 33%, 28%, and 20%, respectively. No differences existed in the median number of diseased vessels
(3, 3, and 3, respectively) or number of grafts per patient (3, 3, and 3, respectively). Composite outcome
improved with increasing internal thoracic artery grafts, whether assessing unadjusted or risk-adjusted data.
Compared with no internal thoracic artery graft, the adjusted hazard ratio was 0.79 (confidence interval,
0.74-0.83) for single internal thoracic artery grafting and 0.70 (confidence interval, 0.62-0.80) for multiple
internal thoracic artery grafting (both P<.001), reducing risk by 21% and 30%, respectively.
Conclusions: This study confirms improved patient outcomes with multiple internal thoracic artery grafting,
achieving half again as much benefit as single internal thoracic artery grafting alone. The data suggest that in-
creasing application of multiple internal thoracic artery grafting should be encouraged to mitigate the inherent
risks and costs of long-term cardiac events. (J Thorac Cardiovasc Surg 2013;145:970-5)Frommultiple analyses, it is clear that saphenous veins used
for coronary artery bypass grafting (CABG) have limited
life span1 and that internal thoracic artery (ITA) conduits
improve graft patency and clinical results.2-8 Although
a right ITA to left anterior descending (LAD) coronary
bypass was among the first coronary revascularizations
performed and reported in 1967,9 the subject remainede Duke UniversityMedical Center,a Durham, NC; Duke Clinical Research In-
,b Durham, NC; and Centennial Medical Center,c Vanderbilt University,
ille, Tenn.
from the National Heart, Lung, and Blood Institute and CTS Network sup-
the research of Dr Parsa.
res: Authors have nothing to disclose with regard to commercial support.
the 92nd Annual Meeting of The American Association for Thoracic Sur-
San Francisco, California, April 28-May 2, 2012.
d for publication April 30, 2012; revisions received Oct 9, 2012; accepted for
ation Nov 6, 2012; available ahead of print Feb 11, 2013.
for reprints: Cyrus J. Parsa, MD, Division of Thoracic and Cardiovascular
ry, Harbin Clinic, Rome, GA 30165 (E-mail: cyrus.parsa@harbinclinic.com).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.11.093
The Journal of Thoracic and Cardiovascular Surgcontroversial until 1986 when Loop and associates8 pub-
lished significant clinical benefits over venous conduits at
10-year follow-up. Numerous studies also have docu-
mented benefits of multiple ITA (MITA) grafts over single
ITA (SITA) conduits with adjunctive veins, including
reduction in death rates and late cardiac events.2-7
Despite this information, MITA grafts recently were used
in only 12% of CABG cases in Europe10 and 4% of CABG
cases in the United States.11 Even in the SYNTAX trial,
MITA grafting was performed in only 26% of patients.12
Perhaps with all of the available positive data, surgeons
should focus on expanding MITA graft procedures. To bet-
ter illuminate this issue, a single institutional experience
with MITA grafting was examined using a validated data-
base with rigorous follow-up to the ultra long-term. The
goal was to obtain guidance with future clinical decisions.
MATERIALS AND METHODS
Over the 25-year period between 1984 and 2009, 19,482 isolated CABG
procedures were performed for multivessel coronary artery disease at Dukeery c April 2013
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ITA ¼ internal thoracic artery
LAD ¼ left anterior descending
MACE ¼ major adverse cardiac events
MI ¼ myocardial infarction
MITA ¼ multiple internal thoracic artery
NITA ¼ no internal thoracic artery
PCI ¼ percutaneous coronary intervention
RCA ¼ right coronary artery
SITA ¼ single internal thoracic artery
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tics were recorded prospectively,5 and analysis was performed by the inde-
pendent statisticians at the Duke Cardiovascular Databank. By using
mailed questionnaires, phone contact, or National Death Index data, 4 out-
come variables were monitored continuously by the Duke Outcome Group:
nonfatal myocardial infarction (MI), subsequent percutaneous coronary
intervention (PCI), redo CABG, and all-cause death. Institutional review
board approval was obtained before beginning the analysis, and informed
consent was waived. Three clinical cohorts were defined according to graft-
ing strategy: (1) saphenous vein grafts only (no ITA [NITA] n ¼ 1074;
9%), (2) SITA and adjunctive vein grafts (SITA n ¼ 16,881; 87%), and
(3) MITA grafts (MITA n ¼ 728; 4%). In the analysis, patients with
MITA grafts were defined only by the number of distal ITA anastomoses.
Unlike earlier studies that described MITA as ITA grafts to 2 coronary sys-
tems, the data set in the last decade was changed to a Society of Thoracic
Surgeons 2.61 format, and specific distal anastomoses were not available.
Free ITAs comprised less than 5% of arterial grafts2 and therefore were not
differentiated. Likewise, radial artery grafts were performed in only 256 pa-
tients in the whole series and were included with the saphenous vein grafts.
In the analysis, the primary end pointwas a compositemajor adverse car-
diac events (MACE) outcome of all 4 variables (all-cause death, MI, PCI,
and redo CABG). Baseline characteristics assessed in the multivariable
model were year of surgery, age, gender, race, history of PCI, prior
CABG, history of CHF, New York Heart Association class, presence of di-
abetes, left ventricular ejection fraction, presence of left main disease, num-
ber of diseased vessels, presence and grade ofmitral insufficiency, history of
tobacco use, hypertension, peripheral vascular disease, cerebrovascular dis-
ease, history of MI, number of grafts created, and presence of renal failure.
Unadjusted cumulative incidence data for each of the 3 groups (NITA,
SITA, and MITA) were calculated for each outcome variable: nonfatal MI,
subsequent PCI, redo CABG, and all-cause death. Cumulative event rates
were calculated using the Kaplan–Meier method as a function of time after
the index surgery. Cox proportional hazards modeling was used to adjust
for differences in patient baseline characteristics between groups. Cumula-
tive incidence curves for the 4 outcome variables again were generated
after Cox model adjustment. Event-free survival curves (freedom from
composite MACE outcome) were examined without and with risk adjust-
ment by the Cox model. Comparisons between groups in the adjusted set-
ting were performed using area under the curve analysis of composite
outcome.RESULTS
Baseline characteristics of the 3 populations were differ-
ent, with the NITA group being older with more significant
preoperative comorbidities and MITA exhibiting less seri-
ous risk profiles (Table 1). Differences in baselineThe Journal of Thoracic and Cacharacteristics in the NITA, SITA, MITA groups were as
follows: median age 66, 64, and 59 years, respectively; con-
gestive heart failure 22%, 18%, and 13%, respectively;
ejection fraction 0.50, 0.52, and 0.51, respectively; reoper-
ation 10%, 3%, and 7%, respectively; diabetes 27%, 30%,
and 15%, respectively; and female gender 33%, 28%, and
20%, respectively. No statistical differences existed in the
median number of diseased vessels (3, 3, and 3, respec-
tively) or number of grafts required per patient (3, 3, and
3, respectively).
Unadjusted cumulative event analyses suggested that
addition of more ITA conduits was associated with progres-
sively fewer late complications (Figure 1). However, after
risk adjustment of the rawcumulative event data, differences
between groups narrowed as the worse baseline risk profiles
of the NITA group were taken into account. However, even
in the risk-adjusted analysis, adding more ITA grafts pro-
gressively reduced MACE complications over the 25-year
study period (Figure 2). The exception was adjusted mortal-
ity, which was similar between SITA and MITA groups.
However, this level of mortality was achieved in the SITA
group at the cost of more reinterventions (Table 2).
Likewise, unadjusted freedom from MACE composite
outcome improved as more ITAs were used (Figure 3). Af-
ter statistical adjustment, the differences narrowed, but a sta-
tistically and clinically significant benefit persisted for
using more ITA grafts. Compared with NITA, the hazard ra-
tio was 0.79 (confidence interval, 0.74-0.83) for SITA, and
it was 0.70 (confidence interval, 0.62-0.80) for MITA (both
P<.001) (Table 2). Over the 25 years of follow-up, average
area under the curve improvement in adjusted composite
outcome was 21% for SITA versus NITA and 30% for
MITA versus NITA.
DISCUSSION
The present analysis adds to the many studies showing
improved long-term results with MITA grafting.13-17
However, it is interesting to simultaneously assess NITA
procedures, so that both SITA and MITA can be placed
numerically into therapeutic context. Over 25 years of
follow-up, SITA grafting reduced the composite event rate
by 21%, and the addition of another ITA graft (MITA) re-
duced events by half again as much. The precise documen-
tation of nonfatal complications is an important feature of
this study and further illuminates the therapeutic landscape
of ITA grafting. It is now fairly certain that general patient
outcomes are improved by MITA grafting, but this study
showed a new twist. In the age of aggressive interventional
cardiology, adjusted SITA mortality differed minimally
from MITA, but this result was achieved at a cost of more
nonfatal events and interventions. This finding is different
from previous time frames and may demonstrate how prac-
tice outcomes are changing over time. Other factors also
may have been operative (see ‘‘Study Limitations’’),rdiovascular Surgery c Volume 145, Number 4 971
TABLE 1. Baseline characteristics
Variable NITA SITA MITA
P
value
No. (19,482) 1874 (9.6%) 16,881 (86.6%) 728 (3.7%) —
Median age (y) 66 64 59 <.001
Gender female 33.3% 28.5% 19.8% <.001
CHF 21.7% 17.6% 12.6% <.001
Reoperation 10.5% 3.0% 6.9% <.001
Prior PCI 18.6% 13.8% 11.3% <.001
Diabetes 27.3% 29.9% 14.7% <.001
Hypertension 61.5% 63.5% 42.9% <.001
Cerebrovascular
disease
14.1% 11.0% 4.5% <.001
Peripheral vascular
disease
17.7% 14.6% 10.9% <.001
COPD 9.6% 8.2% 3.9% <.001
Median LVEF 0.50 0.52 0.51 <.001
Renal failure 2.4% 2.4% 1.0% .04
3-vessel disease 69% 78% 81% .31
LM disease 26.2% 26.0% 23.5% .31
Median no. of grafts 3 3 3 NS
NITA, No internal thoracic artery; SITA, single internal thoracic artery; MITA, multi-
ple internal thoracic artery; CHF, congestive heart failure; PCI, percutaneous coro-
nary intervention; COPD, chronic obstructive pulmonary disease; LVEF, left
ventricular ejection fraction; LM, left main; NS, not significant.
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Dincluding the fact that all survival curves eventually come
back together, and ultra long-term follow-up can be associ-
ated with decreasing survival differences.FIGURE 1. Unadjusted cumulative incidence data: nonfatal MI (A), PCI (B),
shown in Figure 3. MI, Myocardial infarction; PCI, percutaneous coronary in
thoracic artery; NITA, no internal thoracic artery; CABG, coronary artery bypa
972 The Journal of Thoracic and Cardiovascular SurgSo why has MITA grafting not been embraced by Amer-
ican surgeons in the face of such compelling data? Even in
our center, the rate of MITA grafting was only 4%, similar
to current national rates in the Society of Thoracic Surgeons
Database.11 Certainly, MITA procedures require more oper-
ative time and are more tedious.2,4,5 Special technical
facility and experience also may be necessary, compared
with routine vein grafts. It can be reasoned that tolerance
of these minor technical inconveniences may be worth
achieving better outcomes for the patients. The general
morbidity of MITA grafting may be increased slightly,
especially regarding sternal discomfort and perioperative
blood requirement. Sternal wound healing and infection
have been reported to be problems with MITA grafting,
especially in diabetic persons.18 However, many authors
have minimized sternal complications by approaches such
as strict infection control, skeletonized ITA harvesting,
and use of topical antibiotic irrigation to minimize sternal
infection.19-21 Thus, it is now clear that routine MITA
grafting is safe, even in diabetic patients, and one might
suggest that no excuse exists for the low national MITA
rates in the United States.
It has been shown that MITA grafting techniques can be
used in excess of 75% of patients with multivessel disease,
and that the relative benefits are just as great in diabetic pa-
tients and the elderly.5 So, it is reasonable to assume that
cardiac surgeons should seriously consider increasingredo CABG (C), and all-cause mortality (D). Number of patients at risk is
tervention; MITA, multiple internal thoracic artery; SITA, single internal
ss grafting.
ery c April 2013
FIGURE 2. Risk-adjusted cumulative incidence data: nonfatal MI (A), PCI (B), redo CABG (C), and all-cause mortality (D). Number of patients at risk is
shown in Figure 3.MI,Myocardial infarction; PCI, percutaneous coronary intervention;MITA, multiple internal thoracic artery; SITA, single internal tho-
racic artery; NITA, no internal thoracic artery; CABG, coronary artery bypass grafting.
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disease. In fact, if surgical therapy is to maintain relevance
in the age of improving interventional cardiologic tech-
niques, surgeons need to optimize outcomes in whatever
way possible, and more MITA grafting is one logical candi-
date. As 3-year SYNTAX results have begun to show an
outcome advantage of CABG over PCI for patients with
a high SYNTAX score (a benefit driven by lower reinterven-
tion rates), it must be acknowledged that 26% of patients in
that study underwent MITA grafting.12 Replicating SYN-
TAX results in the ‘‘real world’’ may warrant increased at-
tention to augmenting MITA use in the general population
undergoing CABG.TABLE 2. Adjusted hazard ratios
End
point
HR (CI)
SITA vs NITA MITA vs NITA MITA vs SITA
P
value
(2 df)
Death 0.77 (0.72-0.82) 0.73 (0.63-0.84) 0.95 (0.83-1.08) <.0001
CABG 0.57 (0.45-0.73) 0.21 (0.10-0.42) 0.36 (0.19-0.71) <.0001
PCI 1.12 (0.97-1.29) 0.77 (0.58-1.01) 0.68 (0.53-0.88) .0041
MI 0.85 (0.75-0.96) 0.69 (0.53-0.90) 0.81 (0.64-1.03) .0071
MACE 0.79 (0.74-0.83) 0.70 (0.62-0.80) 0.89 (0.80-1.00) <.0001
HR, Hazard ratio; CI, confidence interval; SITA, single internal thoracic artery;
NITA, no internal thoracic artery; MITA, multiple internal thoracic artery; CABG,
coronary artery bypass grafting; PCI, percutaneous coronary intervention;
MI, myocardial infarction; MACE, major adverse cardiac event.
The Journal of Thoracic and CaNumerous studies also support the use of more radial ar-
tery grafts. With the use of careful harvesting and prepara-
tion techniques, as well as routine calcium channel
blockade and fresh heparinized blood distension, the
Brompton Hospital study22 showed excellent results with
radial artery grafting, achieving 5-year patency rates in ex-
cess of 95%, and approaching those of ITA grafts. Numer-
ous reports of radial artery grafting also have shown better
clinical outcomes.23-25 Many centers now have undertaken
programs of ‘‘all-arterial’’ coronary bypass, and with 2 ITA
grafts and 2 radial arteries, most patients with multivessel
disease can undergo all-arterial bypass. It should be empha-
sized that MITA grafting should be the central feature of
such an approach.
Although left ITA grafts to the LAD or circumflex coro-
nary arteries have approximately 100% patency, results
with the right ITA graft often have been suboptimal. Right
ITA grafts to the circumflex coronary artery through the
transverse sinus can exhibit kinking,2 although methods
such as retro-caval placement have shown promise. Right
ITA grafts to the distal right coronary artery (RCA) can
get stretched over the right atrium, and right ITA to distal
RCA bypass frequently is not feasible because of length
limitations. With experience, these problems can be over-
come and MITA grafting facilitated by several techniques.
Skeletonized harvesting or pedicle ‘‘slits’’ can increase
ITA length, and a ‘‘pulley stitch’’ can decrease the distancerdiovascular Surgery c Volume 145, Number 4 973
FIGURE 3. Event-free survival probability for composite outcome: unad-
justed (A) and risk-adjusted (B) data. MITA, Multiple internal thoracic ar-
tery; SITA, single internal thoracic artery; NITA, no internal thoracic artery.
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out tension.5 Most important, use of the right ITA to graft
the LAD across the midline achieves an approximate
100% patency for the right ITA graft and has been the dom-
inant LAD grafting technique in several series (two thirds of
MITA cases in our series2,5). Covering the conduit with the
thymic fat pad at the end of the procedure prevents
subsequent injury during reentry (although only 4%-5%
required reoperation at 20 years). Free ITA grafts also
improve use with difficult anatomy, and again, free grafts
have excellent patencies. So as long as the 2 largest
coronary systems are grafted with ITAs, the exact
combination is not critical, but it is important to use high-
patency configurations.26 When radial arteries are added
for additional grafts (together with frequent use of sequen-
tial arterial grafts as an ‘‘all-arterial’’ configuration), late
complications of saphenous vein closures can be markedly
reduced.27974 The Journal of Thoracic and Cardiovascular SurgStudy Limitations
The present study is limited by observational design.
Undefined confounding variables or treatment selection
biases are always possible. The lack of definition of distal
vessel anastomoses in the past decade also could have
been problematic. We have previously shown that MITA
grafts are most effective prognostically if placed to 2 differ-
ent coronary systems. Sequential MITA grafts to the same
coronary system influence outcome more like single ITA
bypass, and including sequential grafts with the MITA
group in this analysis could have weakened observed
MITA benefits. Thus, the effects of MITA grafting on
both event rates and mortality differences could have been
underestimated in this study. Moreover, all 3 groups had dif-
ferent baseline characteristics, and inadequacies in risk ad-
justment could have existed. Coronary risk factor analysis
and follow-up techniques in the Duke Databank are now
mature, but follow-up can be difficult. However, the tech-
niques used by the independent Duke Followup Group are
state of the art, and all-important coronary variables are de-
fined precisely in the Databank. In fact, Duke observational
results have almost exactly mirrored most randomized tri-
als,28 adding credence to the current data. At present, ran-
domized MITA comparisons are being generated29 and
should further improve our understanding. However,
longer-term data spanning greater than 2 decades, as pre-
sented in this article, are useful in providing guidance for
current clinical management.
CONCLUSIONS
This study and other recent literature suggest that
increasing application of MITA grafting should be encour-
aged to mitigate the inherent risks and costs of long-term
cardiac events after CABG. In coming years, MITA and
all-arterial coronary bypass could play an increasingly
important role in the treatment of coronary artery disease.
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